Table 3 Tests results

From: Diagnosis of HPV-driven head and neck cancer with a single test in routine clinical practice

 

% tumor cells in FFPE (fresh frozen) samples

qRT–PCR

RNAscope HPV-test

p16 IHC

DNA-ISH

1

40 (70)

Negative

Negative

Negative

Negative

2

90 (70)

Negative

Negative

Negative

Negative

3

50 (80)

Negative

Negative

Negative

Negative

4

70 (80)

Negative

positive

positive

Negative

5

60 (80)

Positive (++, HPV16)

Positive

Positive

Positive

6

80 (90)

Positive (+++, HPV33)

Positive

Positive

Negative

7

90 (70)

Negative

Negative

Negative

Negative

8

30 (30)

Negative

Negative

Negative

Negative

9

80 (60)

Positive (+, HPV16)

Positive

Positive

Positive

10

90 (90)

Positive (+++, HPV18)

Positive

Positive

Positive

11

70 (60)

Negative

Negative

Negative

Positive

12

30 (60)

Negative

Negative

Negative

Negative

13

80 (50)

Negative

Negative

Negative

Positive

14

80 (50)

Negative

Negative

Positive

Negative

15

90 (90)

Positive (+++, HPV16)

Positive

Positive

Positive

16

80 (40)

Positive (++, HPV16)

Positive

Positive

Positive

17

70 (80)

Positive (+, HPV16)

Positive

Positive

Positive

18

90 (90)

Negative

Negative

Negative

Negative

19

70

NA

Positive

Positive

Positive

20

80

NA

Positive

Positive

Positive

21

80

NA

Positive

Positive

Positive

22

80 (90)

Negative

Negative

Negative

Negative

23

60

Negative

Negative

Negative

NA

24

70

NA

Positive

Positive

Positive

25

80 (80)

Positive (+++, HPV33)

Positive

Positive

Positive

26

70

Positive (+++, HPV16)

Positive

Positive

Positive

27

60

Positive (+, HPV 16)

Positive

Positive

Positive

28

70

Positive (+++, HPV18)

Positive

Positive

NA

29

70 (90)

Negative

Positive

Negative

Positive

30

80 (90)

Negative

Negative

Negative

Negative

31

90 (80)

Positive (+++, HPV16)

Positive

Positive

Positive

32

60 (70)

Positive (+, HPV16)

Positive

Positive

Positive

33

80 (80)

Positive (++, HPV16)

Positive

Positive

Positive

34

70 (80)

Positive (+, HPV 33)

Negative

Positive

Negative

35

70

NA

Positive

Positive

Positive

36

70

NA

Positive

Positive

Positive

37

40 (30)

Positive (+, HPV16)

Positive

Positive

Positive

38

90 (90)

Positive (+++, HPV16)

Positive

Positive

Positive

39

80 (90)

Positive (+++, HPV16)

Positive

Positive

Positive

40

60 (80)

Positive (+++, HPV16)

Positive

Positive

Positive

41

80 (70)

Negative

Negative

Negative

Positive

42

70 (90)

Positive (+++, HPV16)

Positive

Positive

Positive

43

80 (50)

Positive (+++, HPV16)

Positive

Positive

Positive

44

70 (80)

Positive (+++, HPV16)

Positive

Positive

Positive

45

50 (70)

Positive (+, HPV16)

Positive

Positive

Positive

46

40 (60)

Positive (+, HPV16)

Positive

Positive

Negative

47

80 (70)

Positive (++, HPV16)

Positive

Positive

Negative

48

40 (60)

Negative

Negative

Negative

Negative

49

60 (90)

Positive (+, HPV16)

Positive

Negative

Negative

50

80 (80)

Positive (++, HPV16)

Negative

Positive

Negative

  1. Abbreviations: IHC, immunohistochemistry; ISH, in situ hybridization; NA, not available; qRT–PCR, quantitative real-time–PCR.
  2. Relative gene expression quantification: +(low), ++(intermediate), and +++(high).